Are you Dr. Springett?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 100 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
12902 Usf Magnolia Dr
Tampa, FL 33612Phone+1 813-745-4673
Summary
- Dr. Gregory Springett, MD is an oncologist in Tampa, Florida. He is currently licensed to practice medicine in Florida. He is an Assistant Professor at USF-Morsani.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2000 - 2004
University of MarylandResidency, Internal Medicine, 1998 - 2000
Harvard Medical SchoolClass of 1998
Certifications & Licensure
FL State Medical License 2004 - 2025
Clinical Trials
- A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer Start of enrollment: 2007 Apr 01
- Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery Start of enrollment: 2009 Mar 01
- Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia Start of enrollment: 2009 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 303 citationsAxitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 studyHedy L. Kindler, Tatsuya Ioka, Dirk J. Richel, Jaafar Bennouna, Richard Letourneau
The Lancet. Oncology. 2011-03-01 - 144 citationsPhase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid TumorsAdil Daud, Michelle T. Ashworth, Jonathan Strosberg, Jonathan W. Goldman, David S. Mendelson
Journal of Clinical Oncology. 2015-03-20 - 8 citationsPhase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancerYaman Suleiman, Amit Mahipal, David Shibata, Erin M. Siegel, Helen Jump
Cancer Chemotherapy and Pharmacology. 2015-07-01
Grant Support
- Validating And Targeting Lysophosphatidic Acid Acyltransferase-Beta In CancerNational Cancer Institute2009–2011
- Minority Predoctoral Fellowship Program--NigmsNational Human Genome Research Institute1997
- Minority Predoctoral Fellowship Program--NigmsNational Human Genome Research Institute1991–1996
